<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04223791</url>
  </required_header>
  <id_info>
    <org_study_id>8591A-018</org_study_id>
    <secondary_id>2019-000587-23</secondary_id>
    <secondary_id>MK-8591A-018</secondary_id>
    <secondary_id>205166</secondary_id>
    <nct_id>NCT04223791</nct_id>
  </id_info>
  <brief_title>Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018)</brief_title>
  <official_title>A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate a Switch to Doravirine/Islatravir (DOR/ISL) Once-Daily in Participants With HIV- 1 Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the safety and efficacy of a switch to MK-8591A (a fixed dose
      combination of doravirine and islatravir) in human immunodeficiency virus -1 (HIV-1)-infected
      participants virologically suppressed on a regimen of bictegravir/emtricitabine/tenofovir
      alafenamide (BIC/FTC/TAF). The primary hypothesis is that a switch to MK-8591A will be
      non-inferior to continued treatment with BIC/FTC/TAF as assessed by the proportion of
      participants with HIV-1 ribonucleic acid (RNA) ≥50 copies/mL at Week 48.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 18, 2020</start_date>
  <completion_date type="Anticipated">September 16, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Participants with (Human Immunodeficiency Virus 1 ribonucleic acid ) HIV-1 RNA ≥50 copies/mL at Week 48</measure>
    <time_frame>Week 48</time_frame>
    <description>Percentage of participants with (Human Immunodeficiency Virus 1 ribonucleic acid) HIV-1 RNA ≥50 copies/mL at Week 48</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Participants with one or more adverse events (AEs) up to Week 48</measure>
    <time_frame>Up to 48 weeks</time_frame>
    <description>Percentage of participants with one or more adverse events (AEs) up to Week 48</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Participants who discontinued study intervention due to an AE up to Week 48</measure>
    <time_frame>Up to 48 weeks</time_frame>
    <description>Percentage of participants who discontinued study intervention due to an AE up to Week 48</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participants with HIV-1 RNA ≥50 copies/mL at Week 96</measure>
    <time_frame>Week 96</time_frame>
    <description>Percentage of participants with HIV-1 RNA ≥50 copies/mL at Week 96</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants with HIV-1 RNA &lt;40 or &lt;50 copies/mL at Week 48</measure>
    <time_frame>Week 48</time_frame>
    <description>Percentage of participants with HIV-1 RNA &lt;40 or &lt;50 copies/mL at Week 48</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants with HIV-1 RNA &lt;40 or &lt;50 copies/mL at Week 96</measure>
    <time_frame>Week 96</time_frame>
    <description>Percentage of participants with HIV-1 RNA &lt;40 or &lt;50 copies/mL at Week 96</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CD4+ T-cell count at Week 48</measure>
    <time_frame>Baseline and Week 48</time_frame>
    <description>Change from baseline in CD4+ T-cell count at Week 48</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CD4+ T-cell count at Week 96</measure>
    <time_frame>Baseline and Week 96</time_frame>
    <description>Change from baseline in CD4+ T-cell count at Week 96</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants with evidence of viral drug resistance-associated substitutions at Week 48</measure>
    <time_frame>Week 48</time_frame>
    <description>Percentage participants with evidence of viral drug resistance-associated substitutions at Week 48</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants with evidence of viral drug resistance-associated substitutions at Week 96</measure>
    <time_frame>Week 96</time_frame>
    <description>Percentage participants with evidence of viral drug resistance-associated substitutions at Week 96</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in body weight at Week 48</measure>
    <time_frame>Baseline and Week 48</time_frame>
    <description>Change from baseline in body weight at Week 48</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in body weight at Week 96</measure>
    <time_frame>Baseline and Week 96</time_frame>
    <description>Change from baseline in body weight at Week 96</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants with one or more AEs up to Week 96</measure>
    <time_frame>Up to Week 96</time_frame>
    <description>Percentage of participants with one or more AEs up to Week 96</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants who discontinued study intervention due to an AE up to Week 96</measure>
    <time_frame>Up to Week 96</time_frame>
    <description>Percentage of participants who discontinued study intervention due to an AE up to Week 96</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">578</enrollment>
  <condition>HIV Infection</condition>
  <arm_group>
    <arm_group_label>DOR/ISL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A fixed dose combination (FDC) of 100 mg doravirine (DOR)/0.75 mg islatravir (ISL) for 96 weeks; and placebo to Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) for 96 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BIC/FTC/TAF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>50 mg bictegravir (BIC), 200 mg emtricitabine (FTC), 25 mg tenofovir alafenamide (TAF) for 96 weeks, and placebo to FDC DOR/ISL for 96 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DOR/ISL</intervention_name>
    <description>100 mg DOR/ 0.75 ISL FDC tablet taken orally once daily</description>
    <arm_group_label>DOR/ISL</arm_group_label>
    <other_name>MK-8591A</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BIC/FTC/TAF</intervention_name>
    <description>50 mg BIC, 200 mg FTC, and 25 mg TAF combined in a single tablet, taken orally once daily</description>
    <arm_group_label>BIC/FTC/TAF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo to BIC/FTC/TAF</intervention_name>
    <description>Placebo to BIC/FTC/TAF in a single tablet taken orally, once daily</description>
    <arm_group_label>DOR/ISL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo to FDC DOR/ISL</intervention_name>
    <description>Placebo to FDC DOR/ISL in a tablet taken orally, once daily</description>
    <arm_group_label>BIC/FTC/TAF</arm_group_label>
    <other_name>Placebo to MK-8591A</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Is HIV-1 positive with plasma (Human Immunodeficiency Virus 1) HIV-1 RNA &lt;50 copies/mL
             at screening.

          -  Has been receiving BIC/FTC/TAF therapy with documented viral suppression (HIV-1 RNA
             &lt;50 copies/mL) for ≥3 months prior to signing informed consent and has no history of
             prior virologic treatment failure on any past or current regimen.

          -  Female is eligible to participate if she is not pregnant or breastfeeding, and at
             least one of the following conditions applies: Is not a woman of childbearing
             potential (WOCBP); is a WOCBP and using an acceptable contraceptive method, or be
             abstinent from heterosexual intercourse as their preferred and usual lifestyle; a
             WOCBP must have a negative highly sensitive pregnancy test ([urine or serum] as
             required by local regulations) within 24 hours before the first dose of study
             intervention; if a urine test cannot be confirmed as negative (e.g. an ambiguous
             result), a serum pregnancy test is required. In such cases, the participant must be
             excluded from participation if the serum pregnancy result is positive;

        Exclusion Criteria:

          -  Has HIV-2 infection

          -  Has an active diagnosis of hepatitis due to any cause, including active Hepatitis B
             Virus (HBV) co-infection

          -  Has a history of malignancy ≤5 years prior to signing informed consent except for
             adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer,
             or cutaneous Kaposi's sarcoma

          -  Is taking or is anticipated to require systemic immunosuppressive therapy, immune
             modulators, or any prohibited therapies

          -  Is currently participating in or has participated in a clinical study with an
             investigational compound or device from 45 days prior to Day 1 through the study
             treatment period.

          -  Has a documented or known virologic resistance to DOR,

          -  Female expects to conceive or donate eggs at any time during the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Toll Free Number</last_name>
    <phone>1-888-577-8839</phone>
    <email>Trialsites@merck.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pueblo Family Physicians ( Site 2717)</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pacific Oaks Medical Group ( Site 2765)</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>310-967-3620</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Men's Health Foundation ( Site 2749)</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>80069</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>310-550-1010</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Los Angeles Medical Center ( Site 2775)</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>323-783-8977</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Eisenhower Medical Center ( Site 2744)</name>
      <address>
        <city>Palm Springs</city>
        <state>California</state>
        <zip>92264</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>760-834-7949</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California, Davis, Division of ID Research ( Site 2702)</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95811</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>916-914-6261</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zuckerberg San Francisco General Hospital UCSF ( Site 2743)</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>4154764082ext353</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Whitman-Walker Clinic ( Site 2728)</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20009</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>202-745-6139</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>TheraFirst Medical Center ( Site 2742)</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>954javascript:void(0)5644222</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Midway Immunology and Research ( Site 2759)</name>
      <address>
        <city>Fort Pierce</city>
        <state>Florida</state>
        <zip>34982</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>772-595-9830</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>AHF South Beach ( Site 2780)</name>
      <address>
        <city>Miami Beach</city>
        <state>Florida</state>
        <zip>33140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>30553814002520</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Kinder Medical Group ( Site 2739)</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33133</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>786-497-4000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Orlando Immunology Center ( Site 2734)</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>407-647-3960</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Triple O Research Institute, P.A. ( Site 2755)</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>561-855-7871</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Augusta University ( Site 2752)</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>706-723-0106</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Infectious Disease Specialists Of Atlanta PC ( Site 2719)</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>404-297-9755</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mercer University ( Site 2738)</name>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <zip>31201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>478-301-5851</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chatham County Health Department ( Site 2731)</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>912-651-1978</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hennepin County Medical Center ( Site 2733)</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55415</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>612-873-7516</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kansas City CARE Clinic ( Site 2718)</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>816-777-2757</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>ID Care ( Site 2751)</name>
      <address>
        <city>Hillsborough</city>
        <state>New Jersey</state>
        <zip>08844</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>908-281-0221 Ext. 164</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montefiore Einstein Center ( Site 2730)</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>718-920-5904</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai ( Site 2700)</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>212-824-7821</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Texas ID Consultants, PA ( Site 2707)</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>214-276-5618</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Crofoot Research Center, Inc. ( Site 2715)</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77098</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>713-526-0005</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>DCOL Center for Clinical Research ( Site 2769)</name>
      <address>
        <city>Longview</city>
        <state>Texas</state>
        <zip>75605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>903-238-8854</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dr. Peter Shalit, MD ( Site 2770)</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>206-624-1441</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Multicare Health System ( Site 2713)</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>253-403-7251</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Vincent's Hospital ( Site 3807)</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+61283821111</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Taylor Square Private Clinic ( Site 3804)</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+61293316151</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Holdsworth House Medical Practice ( Site 3800)</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+61293317228</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Holdsworth House Medical Practice ( Site 3810)</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <zip>4006</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+61293317228</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane and Womens Hospital- Infectious Diseases Unit ( Site 3812)</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4029</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+61738375611</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Alfred Hospital ( Site 3802)</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+61390762296</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prahran Market Clinic (PMC) ( Site 3806)</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3181</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+61395140888</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>LKH Graz West ( Site 3401)</name>
      <address>
        <city>Graz</city>
        <state>Steiermark</state>
        <zip>8020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+4331654666403</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University Vienna ( Site 3402)</name>
      <address>
        <city>Vienna</city>
        <state>Wien</state>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+4314040042480</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sozialmedizinisches Zentrum Sued - Kaiser-Franz-Josef-Spital ( Site 3400)</name>
      <address>
        <city>Vienna</city>
        <state>Wien</state>
        <zip>1100</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+431601912408</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Social Medical Center - Otto Wagner Hospital ( Site 3404)</name>
      <address>
        <city>Vienna</city>
        <state>Wien</state>
        <zip>1145</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+4319106042008</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vancouver ID Research and Care Centre Society ( Site 2800)</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6Z 2C7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>604-642-6429</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hamilton Health Sciences ( Site 2803)</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>905521210073538</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique de Medecine Urbaine du Quartier Latin ( Site 2804)</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2L 4E9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>5142855500</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Medicale L Actuel ( Site 2814)</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2L 4P9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>5145243642271</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helsinki University Hospital ( Site 3200)</name>
      <address>
        <city>Helsinki</city>
        <state>Uusimaa</state>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+358504270802</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Edouard Herriot ( Site 3126)</name>
      <address>
        <city>Lyon</city>
        <state>Ain</state>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33472110230</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Nice Hopital Archet 1 ( Site 3103)</name>
      <address>
        <city>Nice</city>
        <state>Alpes-Maritimes</state>
        <zip>06202</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33413423423</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Europeen Marseille ( Site 3117)</name>
      <address>
        <city>Marseille</city>
        <state>Bouches-du-Rhone</state>
        <zip>13003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33413423423</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Foch ( Site 3129)</name>
      <address>
        <city>Suresnes</city>
        <state>Hauts-de-Seine</state>
        <zip>92151</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33146252093</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Montpellier - Hopital Saint-Eloi ( Site 3121)</name>
      <address>
        <city>Montpellier</city>
        <state>Herault</state>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33467337220</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Hotel Dieu Nantes ( Site 3120)</name>
      <address>
        <city>Nantes</city>
        <state>Loire-Atlantique</state>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33240083372</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Regional du Orleans ( Site 3108)</name>
      <address>
        <city>Orleans</city>
        <state>Loiret</state>
        <zip>45000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33238229588</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Nancy Hopital Brabois Adultes ( Site 3128)</name>
      <address>
        <city>Vandoeuvre les Nancy</city>
        <state>Meurthe-et-Moselle</state>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33383154097</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Tourcoing ( Site 3100)</name>
      <address>
        <city>Tourcoing</city>
        <state>Nord</state>
        <zip>59208</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33320694617</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Saint-Antoine ( Site 3113)</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33149283137</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Pitie Salpetriere ( Site 3111)</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33142160144</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Tenon ( Site 3118)</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+33156017436</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>MVZ Karlsplatz Dr.med.Hans Jaeger ( Site 3002)</name>
      <address>
        <city>Muenchen</city>
        <state>Bayern</state>
        <zip>80335</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+49895587030</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum der LMU München ( Site 3004)</name>
      <address>
        <city>Muenchen</city>
        <state>Bayern</state>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+49 89 4400 53457</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum rechts der Isar der Technischen Universitat ( Site 3005)</name>
      <address>
        <city>Muenchen</city>
        <state>Bayern</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+498941402455</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Infektiologikum ( Site 3001)</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hessen</state>
        <zip>60596</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+49 69 69597230</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover ( Site 3012)</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+495115325155</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Bonn ( Site 3000)</name>
      <address>
        <city>Bonn</city>
        <state>Nordrhein-Westfalen</state>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+49222815421</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Essen ( Site 3007)</name>
      <address>
        <city>Essen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+492017233878</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>ZIBP-Zentrum fur Infektiologie Berlin Prenzlauer Berg GmbH ( Site 3003)</name>
      <address>
        <city>Berlin</city>
        <zip>10439</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+4930233212870</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>EPIMED GmbH ( Site 3008)</name>
      <address>
        <city>Berlin</city>
        <zip>12167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+4930130202834</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>ICH Study Center GmbH &amp; Co.KG ( Site 3009)</name>
      <address>
        <city>Hamburg</city>
        <zip>20146</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+494028407370</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Hamburg- Eppendorf (UKE) ( Site 3010)</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+4940741052682</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico ( Site 3501)</name>
      <address>
        <city>Milano</city>
        <state>Lombardia</state>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+390392339600</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universita' Vita Salute. Ospedale San Raffaele ( Site 3502)</name>
      <address>
        <city>Milano</city>
        <zip>20127</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+390226437934</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera San Paolo ( Site 3503)</name>
      <address>
        <city>Milano</city>
        <zip>20142</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+390281843045</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>ASST Fatebenefratelli-Ospedale Sacco ( Site 3500)</name>
      <address>
        <city>Milano</city>
        <zip>20157</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+390239043490</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Nagoya Medical Center ( Site 7203)</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi</state>
        <zip>460-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+81529511111</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Osaka National Hospital ( Site 7202)</name>
      <address>
        <city>Osaka</city>
        <zip>540-0006</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+81669421331</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Center Hospital of the National Center for Global Health and Medicine ( Site 7201)</name>
      <address>
        <city>Tokyo</city>
        <zip>162-8655</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CAIMED Center - Ponce School of Medicine ( Site 2903)</name>
      <address>
        <city>Ponce</city>
        <zip>00716</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>7878402505</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Puerto Rico CONCRA ( Site 2904)</name>
      <address>
        <city>Rio Piedras</city>
        <zip>00925</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+7877539443</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Research Puerto Rico Inc ( Site 2900)</name>
      <address>
        <city>San Juan</city>
        <zip>00909</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+7877235945</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hope Clinical Research, Inc. ( Site 2902)</name>
      <address>
        <city>San Juan</city>
        <zip>00909</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>7872687078</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Germans Trias i Pujol ( Site 3601)</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona [Barcelona]</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34934656374162</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Vall d Hebron ( Site 3602)</name>
      <address>
        <city>Barcelona</city>
        <state>Barcelona [Barcelona]</state>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34932746000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic i Provincial ( Site 3600)</name>
      <address>
        <city>Barcelona</city>
        <state>Barcelona [Barcelona]</state>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34932275430</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari de Bellvitge ( Site 3612)</name>
      <address>
        <city>LHospitalet de Llobregat</city>
        <state>Barcelona [Barcelona]</state>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34932607667</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Maranon ( Site 3603)</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34915868591</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Infanta Leonor ( Site 3606)</name>
      <address>
        <city>Madrid</city>
        <zip>28031</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34911918281</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramon y Cajal ( Site 3611)</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34913369100</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital 12 de Octubre de Madrid ( Site 3605)</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34917792853</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz ( Site 3604)</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34917277558</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Victoria ( Site 3609)</name>
      <address>
        <city>Malaga</city>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34951032594</phone>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Canada</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Puerto Rico</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>January 8, 2020</study_first_submitted>
  <study_first_submitted_qc>January 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 10, 2020</study_first_posted>
  <last_update_submitted>July 23, 2020</last_update_submitted>
  <last_update_submitted_qc>July 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>4'-ethynyl-2-fluoro-2'-deoxyadenosine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf</ipd_description>
    <ipd_url>http://engagezone.msd.com/ds_documentation.php</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

